Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD): Current Perspectives

Bala Waziri1,2, Raquel Duarte1, Saraladevi Naicker1

  • 1Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Insights

Chronic kidney disease-mineral and bone disorder (CKD-MBD) affects many patients despite guidelines. Recent advances, including fibroblast growth factor 23 (FGF23) and updated KDIGO recommendations, are improving CKD-MBD management.

Area of Science:

  • Nephrology
  • Endocrinology
  • Biochemistry

Background:

  • Chronic kidney disease-mineral and bone disorder (CKD-MBD) remains prevalent despite existing guidelines.
  • Adverse clinical outcomes persist in CKD patients due to CKD-MBD.
  • Continuous research aims to enhance the understanding and management of CKD-MBD.

Purpose of the Study:

  • To provide an overview of the evolving trends in CKD-MBD.
  • To connect historical and contemporary concepts of CKD-MBD.
  • To highlight recent advancements in CKD-MBD research and clinical practice.

Main Methods:

  • Review of scientific literature and clinical trial data.
  • Analysis of the impact of fibroblast growth factor 23 (FGF23) on CKD-MBD pathogenesis.
  • Examination of shifts in diagnostic and therapeutic approaches for CKD-MBD.

Main Results:

  • Discovery of fibroblast growth factor 23 (FGF23)'s role, updating the trade-off hypothesis.
  • Transition from single biomarker measurements to serial monitoring of calcium, phosphate, and parathyroid hormone (PTH).
  • Emergence of new clinical trials leading to updated Kidney Disease-Improving Global Outcomes (KDIGO) guidelines in 2017.

Conclusions:

  • CKD-MBD management has significantly evolved.
  • Understanding of CKD-MBD pathogenesis has advanced with new discoveries like FGF23.
  • Updated guidelines and monitoring strategies offer improved clinical care for CKD-MBD patients.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
486
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
293
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
505
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
252
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
221
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
234